NERR PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
NERR PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
A
HighestReliability
A - HighestIncorporation date
08/02/2013Share capital
100,000.00 PLNPrimary activity
Manufacture of homogenized food preparations and dietetic food (10.86.Z - PKD 2007)Representatives
0Representatives rights
DO SKŁADANIA OŚWIADCZEŃ I PODPISYWANIA W IMIENIU SPÓŁKI UPRAWNIONY JEST W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGOCZŁONEK ZARZĄDU SAMODZIELNIE, NATOMIAST W PRZYPADKU ZARZĄDU ZŁOŻONEGO CO NAJMNIEJ Z DWÓCH CZŁONKÓW DO SKŁADANIA OŚWIADCZEŃ I PODPISYWANIA W IMIENIU SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
404,996Net Profit (zł)
404,996Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 2,167,994 |
| - |
| 180,791 |
| 0.22 |
| - |
| 8.34 |
| 186,670 |
| 0 |
| 662,322 |
| 487,021 |
| 2023 |
|---|
| 3,372,086 |
| - |
| 376,687 |
| 0.37 |
| - |
| 11.17 |
| 693,129 |
| 0 |
| 445,623 |
| 384,892 |
| 2024 |
|---|
| 4,491,080 |
| - |
| 404,996 |
| 0.25 |
| - |
| 9.02 |
| 968,353 |
| 0 |
| 331,000 |
| 329,034 |
| 2024 |
|---|
| 4,491,080 |
| - |
| 404,996 |
| 0.25 |
| - |
| 9.02 |
| 968,353 |
| 0 |
| 331,000 |
| 329,034 |
Turnover (zł)
2024
Turnover (zł)
4,491,080 zł
33 % *
Profit before tax (zł)
-Net Profit (zł)
404,996 zł8 % *
Working capital requirement (%)
0.25 
-32.43 % *
Liquidity ratio
-Net profitability (%)
9.02 %
-19.25 % *
Equity (zł)
968,353 zł40 % *
Current liabilities (zł)
0 zł
- *
Non current liabilities (zł)
331,000 zł-26 % *
Non-current Assets (zł)
329,034 zł
-15 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
NERR PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
15/07/2025 | OD 01.01.2024 DO 31.12.2024 |
16/07/2024 | OD 01.01.2023 DO 31.12.2023 |
14/07/2023 | OD 01.01.2022 DO 31.12.2022 |
14/10/2022 | OD 01.01.2021 DO 31.12.2021 |
15/10/2021 | OD 01.01.2020 DO 31.12.2020 |